Announcements Trials
Browse Landscape

Phase

Phase NA 42Phase 2 13Phase 1/2 12Phase 1 9Phase 2/3 7Phase 3 2Phase EARLY_PHASE1 1

Status

Completed 6Recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Breast 1

Conditions

Unresectable Pancreatic Cancer 1Small Cell Lung Carcinoma 1Liver, Cancer of, Non-Resectable 1Colorectal Neoplasms 1Advanced Intestinal Cancer 1Advanced Gastric Cancer 1Advanced Breast Cancer 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Electroporation × Clear all
NCT06185556 2024-08-23

COLDFIRE-III

Amsterdam UMC, location VUmc

Phase 2/3 Recruiting
78 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03239158 2019-01-25

Bioinformation Therapy for Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Liver, Cancer of, Non-Resectable

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Unresectable Pancreatic Cancer

NCT03240224 2019-01-25

Bioinformation Therapy for Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Breast

Advanced Breast Cancer

NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03350490 2019-01-25

Bioinformation Therapy for Intestinal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Advanced Intestinal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡